March 05, 2008
Michael J. Jandernoa, the former chairman of the board and CEO of Perrigo Company, the nation’s largest manufacturer and marketer of store brand over-the-counter drug and nutritional products, was elected to the Van Andel Institute (VAI) Board of Trustees on February 25. His term is to be effective immediately.
February 26, 2008
Van Andel Institute (VAI) has entered into a multi-year licensing agreement with Children’s Memorial Research Center (CMRC) of Chicago for use of its XenoBase software and database system.
February 19, 2008
Researchers at Van Andel Research Institute (VARI) have slowed the growth of human tumors growing in a mouse model of a common form of kidney cancer by using lethal toxin (or LEPIMAT), the toxin that causes anthrax. LEPIMAT blocks a specific signaling pathway in tumor cells that is required for tumor growth.
February 12, 2008
The Winterfest Celebration hosted by the Peninsular Club on February 7, 2008 raised over $65,000 to benefit Parkinson research at Van Andel Institute.
January 11, 2008
Brian Haab, Ph.D., senior scientific investigator in the Laboratory of Cancer Immunodiagnostics at Van Andel Research Institute (VARI), has been named to the Editorial Advisory Board of the Journal of Proteome Research for a three-year period beginning January 1, 2008.
January 08, 2008
James B. Fahner, M.D., the current and founding division chief of pediatric hematology & oncology and senior administrative physician for philanthropy and community relations at Helen DeVos Children’s Hospital, has been appointed to the Van Andel Research Institute (VARI) Board of Trustees, effective January 1, 2008.